The ability of stem cells to activate different gene expression programs requires the choreographed assembly of trans-acting factors at enhancers and promoters during cell differentiation. In this study, we show that the proteasome acts on specific regulatory regions in embryonic stem (ES) cells to prevent incorrect transcriptional initiation. Chemical or siRNAmediated inhibition of proteasome activity results in increased transcription factor and RNA polymerase II binding and leads to activation of cryptic promoters. Analysis of the binding profiles of different proteasome subunits in normal ES cells and following RNAi knockdown of individual subunits provides evidence for a targeted assembly of the 26S proteasome at specific regulatory elements. Our results suggest that the proteasome promotes a dynamic turnover of transcription factor and Pol II binding at tissue-specific gene domains in ES cells, thereby restricting permissive transcriptional activity and keeping the genes in a potentiated state, ready for activation at later stages.
The ability of stem cells to activate different gene expression programs requires the choreographed assembly of trans-acting factors at enhancers and promoters during cell differentiation. In this study, we show that the proteasome acts on specific regulatory regions in embryonic stem (ES) cells to prevent incorrect transcriptional initiation. Chemical or siRNAmediated inhibition of proteasome activity results in increased transcription factor and RNA polymerase II binding and leads to activation of cryptic promoters. Analysis of the binding profiles of different proteasome subunits in normal ES cells and following RNAi knockdown of individual subunits provides evidence for a targeted assembly of the 26S proteasome at specific regulatory elements. Our results suggest that the proteasome promotes a dynamic turnover of transcription factor and Pol II binding at tissue-specific gene domains in ES cells, thereby restricting permissive transcriptional activity and keeping the genes in a potentiated state, ready for activation at later stages.
INTRODUCTION
Accurate developmental regulation of transcription is critical for the establishment and maintenance of tissuespecific gene expression patterns in higher eukaryotes. Embryonic stem (ES) cells have the ability to activate all somatic gene expression programs during their differentiation into various lineages, and consequently they are able to give rise to every cell type in the body. This property, which is termed pluripotency, raises important questions about how transcriptional competence of lineage-specific genes is maintained at the ES cell stage. There is evidence that in ES cells, tissue-specific genes are primed for transcription at later stages of development and that this is important for maintaining pluripotency (Boyer et al., 2005; Szutorisz and Dillon, 2005) . This primed state is characterized by a generally hyperdynamic state of ES cell chromatin (Meshorer and Misteli, 2006; Perry et al., 2004) . At the same time, localized regions of active histone modifications form early transcription competence marks (ETCMs) in ES cells, and these epigenetic marks have been shown to act as centers for transcription factor recruitment ( Figure 1A ) (Szutorisz et al., 2005a) .
Chromatin modification, general transcription factor (GTF) recruitment, and preinitiation complex (PIC) assembly are key control points for regulating transcription, because they specify where and at which time point RNA polymerase II (Pol II) transcription will be initiated. Site-and stage-specific control of PIC formation presents a particular problem in the permissive chromatin environment of ES cells. In fact, PIC assembly has been shown to be restricted to specific regulatory elements, colocalizing with the ETCM regions (Szutorisz et al., 2005b) . These observations suggest that there are mechanisms that restrict nonspecific transcription factor binding in undifferentiated cells.
The proteasome has recently been implicated in the dynamic control of factor binding to transcriptionally active promoters (Collins and Tansey, 2006) . The 26S proteasome is a highly conserved protease that plays a central role in the control of protein stability in eukaryotic cells. The 26S proteasomal complex is organized into two subcomplexes, the 20S proteolytic core and the 19S regulatory particle ( Figure 1B ). The 20S core is composed of four rings of a-type and b-type subunits with the two inner b rings having proteolytic activity (Groll et al., 2005) . The 19S complex is divided into two components, the base and the lid. The base contains ATPases and nonenzymatic subunits, whereas the proteins that form the lid are thought to be responsible for substrate recognition (Pickart and Cohen, 2004 ).
There is evidence that the proteasome is involved in two different types of mechanism for regulating active promoters. One of these functions depends on the proteolytic activity of the 20S proteasome, which facilitates transcriptional elongation by mediating turnover of promoter bound activators and allowing the initiating RNA polymerase to escape from the promoter (Lipford et al., 2005; Muratani et al., 2005; Perissi and Rosenfeld, 2005) . Recent studies have also identified a second function for the 19S complex, which has been proposed to modulate factor recruitment independently of the 20S core by inducing conformational changes in the targeted proteins (Ferdous Lee et al., 2005; Metivier et al., 2003) . These studies highlight the involvement of the proteasome in the regulation of transcription at fully active genes.
Here we show that proteolytic degradation by the proteasome has a previously undescribed role in controlling transcription factor binding to regulatory regions of cell type-specific gene domains in ES cells. At the pluripotent stage, where tissue-specific gene loci are maintained in a state that is competent for future expression but are still inactive, stable binding of transcription factors and Pol II to specific sequence elements is suppressed by the activity of the proteasome. This mechanism involves direct targeting of the proteasome to intergenic sequences and restricts permissive transcription in ES cells.
RESULTS

Proteasome Inhibition Results in Increased Levels of Intergenic Transcription in a Tissue-Specific Locus in ES Cells
We hypothesized that turnover of transcription factor binding at tissue-specific genes might be a key element that would contribute to maintenance of ES cell pluripotency. Removal of initiation complexes by the proteasome would be a potential mechanism for restricting transcriptional activity in permissive chromatin. To test this hypothesis, we examined the effect of chemical inhibition of proteasome activity on transcription of a tissue-specific locus in mouse embryonic stem cells. The VpreB1 and l5 genes ( Figure 1A ) are activated during the early stages of B cell development under the control of a multicomponent locus control region (LCR); they are fully expressed in pre-B cells and silent in mature B cells . Low-level, permissive transcription is also detectable in the locus in ES cells (Szutorisz et al., 2005a) .
To determine whether transcriptional activity of the l5-VpreB1 locus in pluripotent stem cells is controlled by the proteasome, ES cells were treated with inhibitors that block the proteolytic activity of the 20S core. The effect of proteasome inhibition on transcript levels at different regions in the locus was analyzed in ES cells and was compared with the effect on the active locus in pre-B cells and in mature B cells where the locus is silenced (Figure 1C ). Cells were treated with the proteasome inhibitor MG132, and changes in transcript levels were measured by quantitative real-time RT-PCR (Q-RT-PCR) during a 10 hr time course. Propidium-iodide-(PI) staining followed by FACS analysis showed that an 8 hr incubation in 20 mM MG132 did not substantially affect cell survival ( Figure S1A ). No significant morphological changes were observed in the cultures ( Figure S1B ), and FACS analysis of Oct-4 expression confirmed that short-term proteasome inhibition did not lead to ES cell differentiation (Figure S1C ). Because we were primarily interested in the functioning of regulatory elements and it is known that increased noncoding RNA transcription can be a hallmark of PIC assembly, the analysis focused mainly on the gene promoters and intergenic regulatory sequences. A dramatic increase in transcript level was observed in ES cells only and was restricted to two regions of the locus ( Figure 1C , values are shown as relative differences). One of the sites of increased transcription corresponds to an intergenic element that has been shown to have enhancer activity at the pre-B cell stage (Minaee et al., 2005) . The second affected region extends from the l5 promoter into the l5 gene and includes both introns ( Figure 1C , bottom panel). A small increase was also detected in the introns of the l5 gene in mature B cells but not at the intergenic element. No significant change was found in the active locus in pre-B cells. Treatment with a different proteasome inhibitor (lactacystine) resulted in a similar pattern of increased transcription in ES cells ( Figure S2A ). Control treatments with the protease inhibitor leupeptin and the lysosome inhibitor ammonium-chloride did not lead to any increase in transcription ( Figure S2B ). No increase in transcript levels was detected when primers that amplify spliced l5 RNA (spanning the second intron of the gene) were used ( Figure 1D ), indicating that the induced transcripts are not properly processed or initiated from the main transcription start site (TSS). It is particularly interesting that one of the regions where transcription is affected by proteasome inhibition in ES cells colocalizes with the ETCM, which is a center for factor binding during cell differentiation. As the l5-VpreB1 genes are activated during commitment to the B cell lineage, the chromatin in the ETCM region undergoes remodeling and the resulting local accessibility is reflected in the early appearance of two DNase I hypersensitive sites, HS7 and HS8 (Szutorisz et al., 2005a) .
Increased Transcription of the Intergenic Region following RNAi-Mediated Knockdown of Individual Core Proteasome Subunits Increased transcript levels after chemical inhibition suggest the involvement of the 20S core proteasome. To dissect the role of individual subunits, expression of two core subunits was knocked down using siRNAs. ES cells were transfected with siRNAs against either the b4 or the b7 subunits, and the effect was monitored at 4 hr intervals ( Figure 2A) . Specificity of the knockdown was demonstrated by the fact that there was no significant change in TATA binding protein (TBP) levels and by transfection with control siRNAs against GAPDH. Transfection with the b4 or b7 siRNAs slowed the growth of the cells at late time points ( Figure S3A ), similar to the effect of chemical inhibition.
Knock-down of either the b4 or b7 subunit of the 20S proteasome resulted in a highly specific increase in transcripts in the intergenic region ( Figure 2B ), confirming the effect that was observed using chemical inhibitors. The slightly different timing of the increase might be due to differential physiological responses of the cells to the loss of distinct proteasome subunits, affecting, e.g., transcription rate or RNA stability at the 38 hr time point. It is notable that, compared to chemical inhibition, the promoter region of the l5 gene was less dramatically affected by the specific knockdown of the b4 and b7 subunits (compare Figures 1C and 2B ). Together with the strong induction at the HS7/8 enhancer after specific knockdown of 20S proteasome proteins, this suggests that there could be site-specific recruitment of different proteasome subunits.
Proteasome Inhibition in ES Cells Triggers the Activation of Intergenic Promoters
Two explanations can be put forward to explain the change in transcriptional activity in the intergenic region following proteasome inhibition. One possibility is that there is an increased transcription rate that might involve more frequent reinitiation cycles from already active promoters due to lower turnover of activator binding. The other potential explanation is de novo activation of previously inactive promoters, and this would be reflected in the appearance of new initiation sites.
In order to investigate whether proteasome inhibition leads to new initiation events in ES cells, transcription start sites in the l5-VpreB1 locus were mapped by 5 0 RACE following proteasome inhibition (strategy is shown in Figure S4A ). RACE-PCR products were cloned and sequenced to determine the 5 0 ends. The location of the transcription start sites is shown in Figure 3A . Consistent with our previous analysis (Szutorisz et al., 2005a) , transcripts that initiated correctly from the main l5 TSS were not found in untreated ES cells, and a cluster of antisense (opposite direction to the l5 gene) transcripts in the ETCM/HS8 region was observed.
A number of new initiation sites were identified following inhibition of proteasome activity ( Figures 3A and S4B ). The most prominent group of start sites (transcribing in the sense direction) was found within an 800 bp region between HS7 and the l5 promoter. No initiation sites were observed in this region in untreated cells. Another tightly localized cluster of antisense start sites was identified in the HS8 region. There was also a significant change in the pattern of initiation at HS8 with the 5 0 ends reorganized into a single, discrete cluster. Transcription start sites were not detected in the HS7 region. Instead, de novo initiation events were found upstream and downstream (A) Knockdown of the b4 and b7 subunits. Protein levels were analyzed by western blotting at different time points after transfection with siRNAs. Controls using nonspecific siRNAs (Ctrl) and knockdown of GAPDH showed no effect on the expression of proteasome subunits. TBP, loading control. (B) Effect of b4 and b7 knockdown on transcripts relative to ES cells transfected with control siRNAs. See legend to Figure 1C for details of quantification. Error bars are propagated standard deviations from two independent transfections. X axes, time (hr) posttransfection and no RT controls (À). Analysis of MLN51 mRNA shows no effect of proteasome knockdown on transcription of a ubiquitously expressed gene. of HS7, resulting in bidirectional transcription. These results could be explained by the presence of a strong bidirectional promoter in the HS7/8 region, which is suppressed by the proteasome in ES cells. The third cluster of start sites (transcribing in the sense direction) was detected in the first exon and intron of the l5 gene. The pattern of initiation sites described above is consistent with the effect of proteasome inhibition on transcript levels ( Figure 1C ).
Induction of Transcription following Proteasome Inhibition Correlates with Increased Factor Binding to the Intergenic Regulatory Region
The finding that proteasome inhibition gives rise to new intergenic transcription initiation sites in ES cells suggested that the proteasome might be involved in suppressing preinitiation complex formation. To investigate this hypothesis, the binding profile of several initiation factors was analyzed by chromatin immunoprecipitation (ChIP). The TBP and TBP-associated factors 5 and 10 (TAF5 and TAF10) can be components of the TFIID or the TBP-free TAFcontaining (TFTC) complexes (Muller and Tora, 2004) . Transformation-transactivation-domain-associated protein (TRRAP) is a coactivator in different histone acetyltransferase (HAT) complexes (Frank et al., 2003; Liu et al., 2003b) . Brg1 is a subunit of the SWI/SNF ATPdependent chromatin-remodeling complex (Muchardt and Yaniv, 2001 ). All of these factors are expressed ubiquitously ( Figure S5A ) and are known to play important roles in the assembly of PICs. The results obtained for untreated cells are shown in Figure S5 . Consistent with our previous results, the main sites of Pol II binding in ES cells are at the promoter of the Topo3b gene and in the intergenic region between the VpreB1 and l5 genes ( Figure S5B ). In pre-B cells, the active l5-VpreB1 domain is characterized by high-level, locus-wide transcription factor binding (Szutorisz et al., 2005a) . In mature B cells, where the VpreB1 and l5 genes are silent, some Brg1, TAF10, and Pol II binding was still detectable in the locus ( Figure S5D ).
Inhibitor treatment results in three types of specific effects. Firstly, binding of factors to the l5-VpreB1 locus is increased by proteasome inhibition only in ES cells ( Figure 3B ) and mature B cells ( Figure 3D ) where the genes are inactive. Proteasome inhibition resulted in increased binding of TBP, TRRAP, Brg1, and Pol II in these cell types. Binding was not significantly affected in pre-B cells, where transcription of the VpreB1 and l5 genes is fully active ( Figure 3C ). Secondly, it is only in ES cells that increased Pol II binding is detected in the locus, consistent with the observation that proteasome inhibition at the ES cell stage results in elevated transcript levels in the intergenic region ( Figures 1C and 2B) . The third feature of the effect of proteasome inhibition on factor binding and transcription is the localization of much of the increased binding of TBP, Brg1, TRRAP, and Pol II to the intergenic region between the VpreB1 and l5 genes in ES cells.
One possible explanation for the increased binding of factors in ES cells would be a globally higher protein level in the cell due to proteasome inhibition. MG132-treatment results in accumulation of polyubiquitylated proteins and an increase in the level of Mdm2, which is known to be a target for the proteasome ( Figure 3E ). However, western blot analysis of extracts from MG132-treated ES cells showed no significant increase in Brg1, TBP, and Pol II levels ( Figure 3E ). This, together with the fact that increased binding was only observed at some sites (Figure 3B) , indicates that proteasome inhibition affects specific binding rather than global stability of these factors in ES cells. In mature B cells, where the l5-VpreB1 locus is silenced, levels of Pol II binding ( Figure 3D ) and transcription ( Figure 1C) showed only a very modest change, despite the presence of increased TBP and TRRAP binding. This could be a consequence of a less accessible chromatin structure and the binding of tissue-specific repressors in differentiated cells.
We were interested in establishing whether the HS7/8 region might be able to affect transcription of other sequences in the locus at the ES cell stage. To test the effect of the HS7/8 fragment on transcription, the fragment was inserted upstream of the l5 promoter linked to a promoterless human b-globin gene ( Figure 3F ) and analyzed by transient transfection of ES cells ( Figure 3G ). The l5 promoter-reporter construct was expressed at low levels in ES cells, and insertion of the HS7/8 fragment resulted in a greater than 6-fold increase in reporter transcription. RACE analysis of 5 0 ends showed that the transcripts initiate from the b-globin gene and not from the HS7/8 region (data not shown). These results suggest that the HS7/8 fragment contains positive regulatory sequences that can influence transcriptional activity of other regions of the locus in ES cells.
Subunits of the 20S and 19S Proteasome
Are Recruited to the Intergenic Region Site-specific regulation of transcription by the proteasome raises the question of how the proteasome targets the affected regions in ES cells. To address this question, ChIP analysis was carried out to investigate the binding of different 20S and 19S subunits to the intergenic region of the l5-VpreB1 locus. The 20S core complex subunits a4, b4, and b6 and the 19S proteasome subunits Rpt6 and Rpn12 were chosen for analysis. Rpt6 is an ATPase that is located in the base of the 19S particle and has been linked to proteolysis-independent transcriptional regulation ( Figure 1B ). Rpn12 is a nonenzymatic component of the lid, which has been suggested to participate in substrate recognition ( Figure 1B) (Wilkinson et al., 2000) . All five proteasome subunits are expressed at equal levels in ES cells and differentiated cell types ( Figure 4A ).
In the absence of proteasome inhibition, binding of the 20S subunit a4 was observed in the region of the enhancer where HS7 forms at later stages of B cell development ( Figure 4B, left) . Lower levels of a4 and b4 occupancy were found in the HS8 region. No significant binding of 19S subunits was detectable under these conditions. When ES cells were treated with proteasome inhibitor ( Figure 4B , right), no increase was detected for a4 and b4, suggesting a relatively stable binding of these proteins, but a large increase in the binding of the core subunit b6 and the lid subunit Rpn12 was observed with the biggest difference detected in the HS7 region ( Figure 4B , right). This dramatic increase indicates a highly dynamic regulation of recruitment and release of b6 and Rpn12 that depends on proteasome activity. Comparison of proteasome subunit binding in ES cells and differentiated cells showed that the recruitment of the proteasome to regulatory regions is a specific feature of ES cells (Figure S6) . These data lead us to conclude that the control of transcription factor binding at a tissue-specific locus in ES cells involves direct recruitment of proteasome subunits to the sites where regulation occurs.
The 26S Proteasome Is Assembled at the Targeted Sequences through Recruitment of Different Subunits or Subcomplexes
It is particularly interesting that a4 and b4 binding to the intergenic region is observed in ES cells in the absence of proteasome inhibition, whereas significant b6 and Rpn12 occupancy is only detectable when proteasome activity is inhibited. These distinct binding profiles suggest a differential control of recruitment of proteasome subunits or subcomplexes to intergenic regulatory regions. To test this hypothesis, siRNA-mediated knockdown of individual components of the proteasome was combined with ChIP analysis of different subunits ( Figure 4C ). ES cells were transfected with siRNA targeted to the b4 core subunit. Following 26 hr of incubation, the proteasome inhibitor MG132 was added to half of the transfected ES cells. After an additional 8 hr, the cells were harvested and the binding pattern of proteasome subunits was analyzed by ChIP.
Knockdown of b4 resulted in a substantial reduction in the binding of the 20S proteasome subunit a4 in the absence of proteasome inhibition. b4 knockdown also abolished the binding of b6 that is observed following chemical proteasome inhibition. These data suggest a cooperation between different subunits of the core complex in the assembly of the 20S proteasome at the targeted region. In addition, knockdown of b4 resulted in an altered profile of Rpn12 occupancy after MG132 treatment. Rpn12 binding was completely lost from the l5 promoter region and reduced at HS7, but no significant change was detected at HS8, suggesting that Rpn12 can be recruited to the HS8 region independently of the binding of the core proteasome. These results point to the existence of two different types of targeting, as follows: (1) Rpn12 recruitment downstream of HS8 that depends on the binding of core proteasome subunits and (2) a core subunit-independent recruitment of an Rpn12-containing subcomplex to the HS8 region. It is notable that HS8 is also a center for GTF and Pol II recruitment in ES cells, suggesting that at least some Rpn12 binding to HS8 might be associated with the formation of the PIC.
To gain a better insight into the role of Rpn12 in the recruitment of the proteasome to the intergenic region, we used siRNA to directly target Rpn12 expression (Figure 4D) . Knockdown of Rpn12 slowed down ES cell growth ( Figure S3B ) and resulted in increased levels of intergenic transcripts in the HS8 enhancer region (Figure 4E) , similar to the effects that were observed following chemical proteasome inhibition and knockdown of 20S proteasome subunits (compare Figures 1 and 2 with Figure 4E) . The ChIP analysis ( Figure 4F) showed that knockdown of Rpn12 abolished binding of a4 and also blocked the increase in b6 recruitment under conditions of proteasome inhibition. These data suggest that Rpn12 is part of the proteasomal complex that plays a critical role in suppressing permissive transcription in ES cells.
The cooperation of the 20S proteasome with the lid subunit Rpn12 in this mechanism raises additional questions about the involvement of other subunits of the 19S complex in the regulation of permissive transcription. Therefore, we tested whether ATPases, which are located in the base of the 19S proteasome ( Figure 1B) , also participate in assembly of the proteasomal complex and suppression of intergenic transcription by targeting expression of one of the ATPases, Rpt3 (Figures 5A and S3C) . Knockdown of Rpt3 again showed increased levels of intergenic transcripts ( Figure 5B ). Interestingly, binding of the a4 core proteasome subunit was not abolished, but an altered binding pattern was observed (compare Figures 4B and 5C) . While in normal ES cells the main site of a4 recruitment was HS7, after Rpt3 knockdown, a high level of binding is also detected at HS8. These observations suggest that the a4 subunit is recruited to the intergenic region independently of the Rpt3 ATPase and that a reduced level of Rpt3 in ES cells leads to changes in the recognition of different regions by an a4-containing subcomplex. In addition, Rpt3 knockdown blocked the large increase in b6 and Rpn12 binding that is seen when the proteasome activity is inhibited ( Figure 5C ). The effect of the Rpt3 knockdown also emphasizes the similarity in the regulation of b6 and Rpn12 binding (compare Figures 4B and 5C ) and suggests that ATPase components of the 19S particle are likely to control the turnover of proteasome assembly at the targeted elements.
The Proteasome Controls GTF Binding and Transcriptional Activity at Different Tissue-Specific Gene Loci Our results suggest that proteasome-mediated suppression of factor binding could be a general mechanism for controlling transcription. To investigate this possibility, we analyzed the effects of proteasome inhibition on two additional, well-characterized tissue-specific gene loci (b-globin and HoxD4, Figure 6) . Activation of the genes of the mouse b-globin locus during erythroid development is regulated by the LCR (Figure 6A) , and an enhancer element colocalizing with DNase hypersensitive site 2 (HS2) of the LCR has been shown to be a major site for transcription factor recruitment (Vieira et al., 2004) . The mouse HoxD4 gene is expressed in neurons under the control of an enhancer located 3 0 of the gene ( Figure 6B ) (Rastegar et al., 2004) . The common feature of all three domains that have been investigated in this study is that their regulation involves the formation of a localized GTF recruitment center in regulatory regions during the early stages of development (Szutorisz et al., 2005b) .
In the b-globin locus, MG132-treatment resulted in increased levels of Pol II and TBP binding with the most prominent increase observed in the HS2 enhancer region ( Figure 6C, top panel, left) . This correlates with elevated transcript levels at HS2 ( Figure 6C, bottom panel, left) . The HS2 region in the b-globin locus is not only the principal early stage-specific GTF recruitment center but also contains a major cluster of noncoding RNA transcription start sites (Routledge and Proudfoot, 2002) suggesting a functional similarity to HS8 in the l5-VpreB1 locus. In the HoxD4 locus, increased TBP and Pol II binding (Figure 6C, top panel, right) and a modest induction of transcription ( Figure 6C , bottom panel, right) was detected at the 3 0 enhancer following proteasome inhibition. Lastly, we examined the binding profiles of the a4, b6 and Rpn12 proteasome subunits at the b-globin and the HoxD4 loci. In untreated ES cells ( Figure 6D ), only binding of a4 was observed, with the highest level found at the HS2 enhancer in the b-globin locus. Following proteasome inhibition, increased binding of a4, b6, and Rpn12 was detected in regulatory regions of the b-globin and the HoxD4 loci ( Figure 6E ). The observed binding characteristics of Rpn12 closely resemble the profile that was seen in the l5-VpreB1 locus (see Figure 4B ). Taken together, the data from three different domains suggest a widespread involvement of the proteasome in the control of GTF binding and transcription at regulatory regions of tissue-specific gene loci in ES cells.
DISCUSSION
The data from this study identify an entirely new function for the proteasome as a transcriptional silencer that blocks nonspecific transcription initiation in intergenic and intragenic regions in ES cells through a mechanism that depends on the proteolytic activity of the 20S core (Figure 7) . The effects of the proteasome on transcription that have been identified to date relate to gene activation. In addition to the nonproteolytic roles of the 19S regulatory particle (see Introduction), previous studies in yeast (Lipford et al., 2005; Muratani et al., 2005) and mammalian cells (Kang et al., 2002; Reid et al., 2003) have established that the proteolytic activity of the proteasome plays a critical role in the initiation and elongation stages of transcription and also removes stalled Pol II from coding regions and the 3 0 ends of active genes to facilitate the termination of transcription (Gillette et al., 2004; Somesh et al., 2005) . Our results provide evidence that the proteolytic activity of the proteasome silences permissive transcription in ES What allows the proteasome to have these different effects? The extensively characterized stimulatory effect of the proteasome on gene transcription is mediated by specific interactions between proteasome subunits and transcription factors (Collins and Tansey, 2006) . The distinction between this type of activating function of the proteasome at gene promoters and the silencing effect on intergenic transcription that we observe in ES cells might be due to differences in the regulation of promoter-specific and nonspecific initiation events (Carrozza et al., 2005) . Specificity of transcriptional initiation is controlled by activators that play key roles not only in the targeting of the basal transcription machinery but also in stabilizing the initiation complexes at promoters (Black et al., 2006; Yudkovsky et al., 2000) .
The nonspecific, intergenic, and intragenic transcription that is observed in ES cells occurs in a highly accessible chromatin context in the absence of tissuespecific activators. We speculate that this leads to formation of incomplete PICs in intergenic regulatory regions of tissue-specific gene domains that have an altered conformation and composition compared to ''normal'' PICs, which are stabilized by activators (Figure 7) . The abnormal structure of nonspecifically assembled PICs would make these complexes or some of their subunits targets for proteasomal degradation (Asher et al., 2006) . There is a growing body of evidence that incorrectly folded proteins are subject to proteolysis by a variant 20S core complex, which can target substrates even in the absence of ATP and ubiquitylation (Baugh and Pilipenko, 2004; Li et al., 2006; Liu et al., 2003a) . 
Targeting of the Proteasome to Different Types of Regulatory Elements
A model to explain the targeting of different subcomplexes of the proteasome to specific regions in ES cells is shown in Figure 7A . A central feature of the model is the presence of two different types of preinitiation complex in the intergenic region. One type of PIC (PIC I) would be recruited to the ETCM region by sequence-specific activators, where it forms part of a center for recruitment of Pol II to the locus (Szutorisz et al., 2005b) . In addition to this, a second type of PIC (PIC II) would form nonspecifically, leading to what is termed permissive transcription. We propose that the proteasome plays different roles in the assembly/disassembly of these two types of PIC.
The analysis of binding of the Rpn12 lid subunit to the l5-VpreB1 locus and the effect of Rpn12 knockdown on transcription suggests that Rpn12 is involved in the regulation of both specific and nonspecific PICs ( Figure 7A , PIC I and PIC II). In addition, the observation that Rpn12 recruitment depends on the presence of the Rpt3 ATPase ( Figure 5C ) implies that Rpn12 is targeted to intergenic elements as part of a 19S base-lid complex. Evidence for differential targeting of proteasome subcomplexes comes from two different observations. Firstly, an Rpn12-containing 19S subcomplex binds to the ETCM region even after RNAi-induced loss of core proteasome binding (Figures 4C, 5C , and 7A, PIC I). During recruitment of GTFs to the ETCM, this 19S subcomplex would have a chaperone function as part of the activator-dependent PIC, similar to the stimulatory role that has been described for the regulation of gene transcription (Collins and Tansey, 2006) . Secondly, Rpn12 knockdown in ES cells abolishes targeting of the 20S core complex to the cryptic promoters and blocks the suppressive effect of the proteasome on permissive transcription (Figures 4F and 7A, PIC II) . The fact that knockdown of subunits of the core, lid, and base components of the proteasome all leads to increased intergenic transcription is evidence that after recruitment through different subcomplexes, the 19S and 20S particles are assembled into a functional 26S proteasome, which removes PICs from the sites of permissive transcription ( Figure 7A , step 2, PIC II). However, the observation that the loss of Rpt3, an ATPase component of the 19S regulatory particle, does not abolish the recruitment of the core proteasome subunit a4 ( Figure 5C ) suggests that the 20S and 19S proteasome subcomplexes are recruited separately to PICs that are targeted for degradation. In this respect, it is notable that several recent studies have reported differential targeting of 19S and 20S proteasomal subcomplexes to genomic regions in yeast (Auld et al., 2006; Sikder et al., 2006) and human tumor cells (Rasti et al., 2006) .
A further unexpected finding from this study is the observation that Rpn12 and b6 occupancy in regulatory (A) Dynamic assembly of the proteasome at intergenic regulatory elements. Proteasomal subcomplexes are recruited to two different types of PIC (step 1). A 19S subcomplex would facilitate the formation of productive initiation complexes recruited to the ETCM region by a sequence-specific activator (PIC I). PICs assembled on cryptic promoters in the absence of an activator (PIC II) are targeted both by the 20S core complex and the 19S regulatory particle. Here, the 19S and 20S particles are assembled into a functional 26S proteasome, which removes PICs, thereby suppressing permissive transcription (step 2). Our data are consistent with a model of controlled cycles of assembly/disassembly of the 26S proteasome during proteolytic degradation of PIC components (step 3). Curved arrows show dynamic exchange of proteasome subunits b6 and Rpn12. PIC, preinitiation complex; Act, activator; ETCM, early transcription competence mark. (B) The proteasome prevents the expansion of active chromatin regions at tissue-specific loci. Tissue-specific gene loci contain early transcription competence marks (ETCMs) in ES cells that act as centers for transcription factor recruitment. The 26S proteasome targets cryptic promoter elements that are located outside of ETCMs to prevent nonspecific PIC assembly and spreading of the modified chromatin domain. In differentiated cells, the recruitment of lineage-specific activators allows chromatin remodeling and stable PIC assembly at enhancers and promoters, and the resulting PICs would no longer be susceptible to degradation by the 26S proteasome.
regions is only detectable following chemical proteasome inhibition. This could be due to (1) unstable binding of the proteasome to ES cell chromatin or (2) differential accessibility of the chromatin bound proteasome in the presence of the chemical inhibitor. The first explanation raises the possibility of a dynamic autoregulatory mechanism. The data suggest that some of the subunits or subcomplexes (the ones that contain b6 and Rpn12) bind only transiently compared to others (e.g., a subcomplex containing a4) and that the differential binding profile is linked to the proteolytic activity of the proteasome ( Figure 4B ). This can be explained by controlled cycles of assembly and disassembly of the proteasome during the degradation of PIC components ( Figure 7A, step 3, PIC II) . A similar mechanism has been described for the yeast 26S proteasome in vitro, where ATP hydrolysis-dependent disassembly of the 20S and19S particles occurs during each proteolytic cycle (Babbitt et al., 2005) . We cannot rule out the alternative explanation that chemical inhibition alters the conformation or the position of the chromatin bound proteasome, thereby increasing the accessibility of some epitopes for antibody recognition. However, it is notable that knockdown of an ATPase component of the base complex abolished Rpn12 and b6 binding after chemical inhibition ( Figure 5C ), indicating that the dynamic turnover of these subunits is linked to ATPase function during proteolytic cycles. Taken together, our results suggest that not only nonspecific PIC formation but also the assembly of the proteasomes that target these PICs is highly dynamic in ES cells.
Dynamic Turnover of Transcription Factor Binding in ES Cells: A Role for the Proteasome in Maintaining ES Cell Pluripotency
Our results raise interesting questions about the biological significance of permissive transcription in ES cells and its regulation at tissue-specific genes. It has been proposed that low-level permissive transcription of lineage-specific genes in stem cells helps to keep these genes in a dynamic state, ready for activation at later stages (Meshorer and Misteli, 2006) . Our data indicate that there is a substantially greater level of promoter activity in pluripotent stem cells than had previously been detected but that transcription is being suppressed by continuous removal of PICs from cryptic promoters by the proteasome.
In the l5-VpreB1 locus, transcription from the normal initiation sites of the genes is not induced by proteasome inhibition, suggesting that activator-dependent gene promoters are not preferred sites for initiation of permissive transcription ( Figure 7B ). We find a striking clustering of suppressed transcription start sites close to an enhancer in the l5-VpreB1 locus ( Figure 3A) . This enhancer contains a discrete region of active epigenetic modifications (the ETCM). The active histone modifications have been shown to spread from the ETCM into the region containing the cryptic promoter as the cells commit to the B cell lineage (Szutorisz et al., 2005a) . A similar expansion of chromatin modification and factor binding has been observed during the developmental activation of the b-globin, HoxD4, and other tissue-specific loci (Bulger, 2005) . Our observation that binding of components of chromatinmodifying complexes (Brg1 and TRRAP) is restricted by the proteolytic activity of the proteasome (Figure 3 ) suggest a potential mechanism by which the proteasome could prevent the spread of modified, active chromatin in ES cells.
The silencing of nonspecific transcription by the proteasome adds a new dimension to the control of ES cell pluripotency. The results presented in this study suggest that lineage-specific gene loci are in a highly dynamic state in ES cells with factors continuously binding to regulatory sequences and being removed by the proteasome. This control is likely to have the effect of keeping tissuespecific genes in a transcriptionally competent state, ready for activation as the cells differentiate into various lineages.
EXPERIMENTAL PROCEDURES
A detailed version of the experimental procedures can be found in the Supplemental Data.
Cell Culture and Inhibitor Treatments
Mouse E14 ES cell, Pre-B cell, and mature B cell cultures were established and maintained as described in Szutorisz et al. (2005a) . Cells were treated in culture media with 20 mM MG132 (Sigma), 10 mM lactacystine (Calbiochem), 1 mM leupeptin (Sigma), and 20 mM ammonium chloride for the indicated length of time. The condition of the cells was monitored by propidium-iodide-(PI) staining followed by FACS analysis ( Figure S1 ).
RNAi Knockdown in ES Cells
The following siRNAs were purchased from Ambion: b4 (ID no. 70480), b7 (ID no. 164718), Rpn12 (ID no. 183824), Rpt3 (ID no. 187917), positive control for GAPDH, and negative control nonsilencing siRNA. Feeder-free ES cells were transfected with 125 pmole siRNA using the protocol described in the Supplemental Data.
RNA Analysis
Quantitative reverse-transcription PCR (Q-RT-PCR) and rapid amplification of cDNA ends (RACE) were performed as described in the Supplemental Data.
ChIP
Fixed chromatin preparation and ChIP are described in Szutorisz et al. (2005a) . ChIP analysis following siRNA knockdown of proteasome subunits is described in the Supplemental Data. Protein binding in untreated cells is shown as a ratio relative to background (obtained using nonspecific antibodies and without antibody). Changes in binding following proteasome inhibition are expressed as ratios between normalized ChIP signals (compared to background, as above) from inhibitor-treated and untreated cells.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, Supplemental References, and six figures and can be found with this article online at http://www.cell.com/cgi/content/full/127/7/1375/ DC1/.
